Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study (Q41155680)
Jump to navigation
Jump to search
scientific article published on 2 November 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study |
scientific article published on 2 November 2015 |
Statements
1 reference
Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study (English)
1 reference
1 reference
Annemilaï Tijeras-Raballand
0 references
Jean-François Fléjou
1 reference
Dewi Vernerey
1 reference
Franck Bonnetain
1 reference
Armand de Gramont
1 reference
Benoist Chibaudel
1 reference
Annemilaï Tijeras-Raballand
1 reference
Aurelie Scriva
1 reference
Tamas Hickish
1 reference
Jean Luc Van Laethem
1 reference
Maria Banzi
1 reference
Eduard Maartense
1 reference
Einat Shmueli
1 reference
Goran U Carlsson
1 reference
Werner Scheithauer
1 reference
Demetris Papamichael
1 reference
Marcus Möehler
1 reference
Pieter Demetter
1 reference
Soudhir Colote
1 reference
Christophe Tournigand
1 reference
Christophe Louvet
1 reference
Alex Duval
1 reference
Aimery de Gramont
1 reference
2 November 2015
1 reference
1 reference
Identifiers
1 reference